Project Details
Description
DEVELOPMENT OF A NOVEL PLATFORM FOR IN VIVO DELIVERY OF ANTAGOMIRS TO STUDY CETUXIMAB RESISTANCE IN COLORECTAL CANCER
| Status | Finished |
|---|---|
| Effective start/end date | 11/15/20 → 09/30/23 |
Funding
- US Army Medical Research Acquisition Activity: $427,098.05
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.